Medical Device Biocompatibility

 

Medical devices require varying degrees of biocompatibility testing according to their classification. The main source of guidance on the essential requirements for biological safety is ISO 10993:2003 Biological evaluation of medical devices. This standard defines devices in terms of their invasiveness and duration of patient contact and subsequently determines what level of safety testing manufacturers need to successfully complete prior to putting their product on the market.

Check our Medical Device Biocompatibility Test Requirements Chart   Biological Safety Testing ISO 10993 for a quick assessment of your product.

Whatever your device, MET will guide you through this critical path and give you accurate advice on the minimum testing requirements for both CE marking and FDA submissions. All our testing is carried out under rigorous laboratory control. Good Laboratory Practice (GLP) testing is also available as an option. You can have complete confidence in having the correct portfolio of tests in your technical file and universal acceptance of the results.

Contact us today for advice, time scale and a free quotation.

Components of ISO 10993 relevant to medical device manufacturers available from MET:

ISO 10993-1:2003   Part 1: Evaluation and testing.

ISO 10993-3:2003   Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity.

ISO 10993-4:2002   Part 4: Selection of tests for interactions with blood.

ISO 10993-5:1999   Part 5: Tests for in vitro cytotoxicity.

ISO 10993-6:2007   Part 6: Tests for local effects after implantation..

ISO 10993-9:1999   Part 9: Framework for identification and quantification of potential degradation products.

ISO 10993-10:2002 Part 10: Tests for irritation and delayed-type hypersensitivity.

ISO 10993-11:2006 Part 11: Tests for systemic toxicity.

ISO 10993-13:1998 Part 13: Identification and quantification of degradation products from polymeric medical devices.

ISO 10993-14:2001 Part 14: Identification and quantification of degradation products from ceramics.

ISO 10993-15:2000 Part 15: Identification and quantification of degradation products from metals and alloys.

ISO 10993-16:1997 Part 16: Toxicokinetic study design for degradation products and leachables

ISO 10993-17:2002 Part 17: Establishment of allowable limits for leachable substances

ISO 10993-18:2005 Part 18: Chemical characterization of materials

ISO/TS 10993-19:2006  Part 19: Physico-chemical, morphological and topographical characterization of materials

ISO/TS 10993-20:2006  Part 20: Principles and methods for immunotoxicology testing of medical devices